Ignite Creation Date:
2025-12-24 @ 11:18 PM
Ignite Modification Date:
2025-12-25 @ 8:58 PM
Study NCT ID:
NCT03605056
Status:
UNKNOWN
Last Update Posted:
2018-07-30
First Post:
2018-07-21
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase 2 Trial of Chidamide-Lenalidomide-Dexamethasone(CRD) Regimen in R/R MM
Sponsor:
Peng Liu
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-07-31
Start Date Type:
ESTIMATED
Primary Completion Date:
2020-07-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-07-31
Completion Date Type:
ESTIMATED
First Submit Date:
2018-07-21
First Submit QC Date:
None
Study First Post Date:
2018-07-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-21
Last Update Post Date:
2018-07-30
Last Update Post Date Type:
ACTUAL